Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 4965-4968

  Hardt, P D ^a   Ngoumou, B K ^a   Rupp, J ^a   Schnell Kretschmer, H ^a   Kloer, H U ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Gastrointestinal cancer; Pyruvate kinase; Tumor marker

Indexed keywords

C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EDETIC ACID; PYRUVATE KINASE; TUMOR MARKER;

CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; PROGNOSIS; PYRUVATE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034450627     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma
2. Quantitativer nachweis von Tumor M2-pyruvatkinase in EDTA-Plasma bei patienten mit lungenkrebserkrankungen
3. TUM2-PK (pyruvate kinase type tumor M2), CA 19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions
4. Quantitative detection of tumor M2-PK in serum and plasma